Mayo Clinic
3-page document: -I- Visit to New York
Fields
Document Images
-I-
Visit to New York
Author: P.N.Lee
Date : 7.11.88
I started my recent US trip by visiting Dr. Nancy Haley (NH) of the
American Health Foundation in New York on October 30th. I had met her a
number of times previously at conferences and she had visited me at my
office last year when in England. She met me from the airport and I had
lunch at her home where we discussed a wide range of issues. Points
found of interest are noted below.
I asked her what the current situation was in regard to the IARC
urinary continue study. In this study, as I understand it, urine was
collected from 200 self-reported non-smoking women in some 10-15 centres
worldwide. The American Health Foundation had completed the chemical
analyses well over a year ago, but no paper had emerged yet describing
the results. NH had written to Riboli, the project organiser at Lyon,
threatening to publish herself if he did not pull his finger out.
She
was over in Brussels in February for the passive smoking conference and
was thinking of going to Lyon then to sort out what was going on. She
said that the studies had shown evidence of denial of smoking, despite
being conducted in a manner likely to minimize it. She said the Japanese
sample had shown 3% of true smokers among the sample. This is equivalen~
to about 15% of smokers denying smoking, given the small proportion of

Japanese women who smoke. She noted that there was a tendency for denial
rates to be higher in countries where smoking was less socially accepted.
She also noted that median cotinine levels resulting from passive smoke
exposure tended to be highest in countries where people spent more time
indoors and lived in smaller rooms. She did not give me sight of any
data.
NH told me that the American Health Foundation were conducting a
study in which they had cholesterol levels and a range of other risk
factors on a large sample. She noted a highly significant, though small,
positive trend in cholesterol level in relation to number of cigarettes
smoked. This trend may reflect differences in diet of smokers and
non-smokers.
She mentioned that Judson Wells is continuing his work at estimating
the number of deaths due to passive smoking. Apparently a paper is due
to appear in Environment International shortly claiming tens of thousands
of deaths a year from all causes - no doubt the figure includes large and
totally unreliable contributions from heart disease and cancer other
than the lung.
DiN had a poor opinion of Barbara Hulka, who was chairman of the
group producing the National Research Council report on passive smoking
and had chaired sessions in Tokyo and at Imperial College.
On the morning of November Ist, I called in briefly at the American
Health Foundation's headquarters in the impressive Ford Foundation
building in New York. I Ealked to Ernest Wynder and to Geoffrey Kabat.
Although Wynder felt the issue of misclassification of active smoking was
important, he also stressed the importance, in case-control studies, of
misclassification of passive smoke exposure. Non-smokers with lung

-3-
cancer were likely to overstate their passive smoking exposure, in an
attempt to explain their disease, relative to non-smokers with a disemse
not associated with smoking. He said that he and Kahat were going to
update their 1984 paper with substantially more cases
and controls.
Their analyses so far had confirmed their earlier
finding
relationship of passive smoking to lung cancer. I was
provided with
recent versions of the questionnaires they use and of a very recent paper
on the effect of low-yield cigarette smoking on lung cancer risk. They
are attached as Appendices. I will review the paper in the near future.
